Troglitazone: a new antihyperglycemic agent.
Troglitazone is the first of a new family of antihyperglycemic drugs. We review its use in clinical practice.
Vidt
D G
DG
Cleveland Clinic, Cleveland Clinic Foundation, OH 44195, USA.
Speerhas
R A
RA
Reddy
S S
SS
D002839:Chromans / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D005943:Gluconeogenesis / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone